Investing With IBD

Legendary three-time U.S. Investing Championship winner David Ryan and IBD Chief Content Officer Chris Gessel reveal the master plan for the new, streamlined FFTY and BOUT. They discuss how rigorous historical backtesting unlocked concrete ways to improve performance and share trading rules that will keep the fund's holdings aligned with the market's true leaders. Ryan explains the importance of letting winners run and shows investors exactly how these upgraded quality-first rules will help them win in today's markets.

In a market where traditional setups look promising only to undercut key levels and trigger stops, playing defense isn’t just an option. It’s an essential survival skill. In this episode, Connor Bates, Portfolio Manager of the TURBOTECTION strategy at Revere Asset Management, dissects how to protect capital when price action gets frustratingly tight and deceptive.

To achieve trading serenity, you don't ignore market volatility. You control it. Market Wizard Tom Basso will share how he reduces the first part of drawdowns and the importance of position sizing for capping risk on both individual stocks and his overall portfolio. The end result gives him an all-weather mindset for difficult markets.

In this episode, we break down Jeff’s latest newsletter research on the upcoming midterm election cycle and what it actually means for your portfolio. Spoiler: the market doesn't care as much about party changes as you think. It just wants uncertainty out of the way. We examine why gridlock often fuels stock market gains, which political setups historically deliver the highest returns, and why expectations for this cycle should be balanced against recent market strength.

In this episode, we unpack the major sector rotation reshaping the markets. After 13 weeks of tech and healthcare trading leadership back and forth, technology has broken out to drive a fresh wave of market bullishness. But this isn't just a mega-cap story—we dive into equal-weight ETFs like RSPT (Equal Weight Tech) and explore what underlying market breadth is really telling us.

In this episode, growth investor John Pocorobba (founder of Rain King) reveals why the market is set up for a massive acceleration phase over the next decade. Historically, major stock market cycles consist of 10- to 15-year sideways consolidations (like 2000–2015) followed by roughly 25-year secular bull markets. According to John, the supercycle that began in 2009 is about to hit its critical acceleration phase between 2028 and 2033.

This week's podcast guest is George Tkaczuk, portfolio manager and 2020 U.S. Investing Championship winner. Tkaczuk will be discussing how to navigate a market full of false starts, as well as the next pivot point he's eyeing in the major indexes.

This week’s podcast guest Matt Caruso offers a different perspective on the choppy action of recent months. Despite everything, Caruso sheds light on how this market might actually be signaling resilience here. Caruso will also discuss why getting the macro thesis right isn't enough. Everyone knows AI is the primary economic driver for the next decade. But true success will come down to specific risk management: knowing precisely when to press your edge and when to preserve capital.

When rattled by sideways markets, you may want to stop all together. But now is the best time to brush up on your trading rules and be ready for when the trend picks up again. Plus, Zor Capital portfolio manager Joe Fahmy offers a broader perspective on the AI trade and why he thinks it’s not over yet.

What does a recent run in U.S. treasuries really mean for the broader markets? Nancy Tengler, CEO and CIO at Laffer Tengler Investments, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss this, and the outcomes investors can expect in September.

Here’s how to handle the big winners. Jim Roppel, founder of The Roppel Report, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss market rotation, crypto’s comeback and why biotech’s best days are still to come.

Measure what you value. Don Vandenbord, chief investment officer at Revere Asset Management, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss whether AI companies can make money, the infrastructure underpinning the market momentum and indicators that help you manage risk.

Check your investment’s vital signs. David Keller joins Investor’s Business Daily’s “Investing with IBD” podcast this week to discuss the broadening market and sector rotations. He also talks about the value-oriented sectors with emerging potential.

Market chop got you confused? IPOs have you running home? Trader Greg Morton explains why keeping records could be the surprising antidote investors need to manage unruly markets. Our guest this week for Investor’s Business Daily’s “Investing with IBD” podcast, he also shares the spreadsheet he uses to track his own portfolio and inform his investing decisions.

Going defensive? Exploring add-on positions? Looking for technical patterns that work? Steve Swetz joins the “Investing with IBD” podcast to discuss how he refines his precision for entering stocks and identifies specific strategies for volatile markets and managing your portfolio.

Are stocks reaching a new inflection point? John Kosar, chief market strategist and portfolio manager at Asbury Research, joins the “Investing with IBD” podcast to discuss why he sees a reduction in risk-taking among investors and where a potential correction takes us next.

With earnings and market rotations setting up traps everywhere for investors, it helps to know how multiple timeframes and other tricks can help you stay afloat. Brian Shannon, founder of Alphatrends.net, discusses how short-term moving averages can help keep your portfolio out of trouble, even in a volatile market.

How do you fit SpaceX into your portfolio? What happens after the lockup? And how much capital could SpaceX need to keep their satellite network alive? Andrew Chanin of Procure AM discusses his work with companies developing early stage space technologies and what investors should consider when investing in space industry stocks.

From “Greenspeak” to “The Warsh Way?” You heard it here first. IBD’s Ed Carson, news editor and resident Fed-watcher, joins the Investing with IBD podcast to talk about the transitory phase, the greatest soft landing you’ve never heard of and why the Fed’s telegraphing might not even matter anyway.

There’s a line between being patient with a stock, and being stubborn. But not knowing the difference will cost you. Jim Lebenthal, chief market strategist at Cerity Partners, joins the “Investing with IBD” podcast to explain how to determine when to stay the course with a stock and when to jump. He also explores why there often aren’t simple answers to investing questions around inflation, artificial intelligence and more.

There’s the emotional side of the follow-through day, and there’s the rational side. How do you overcome the fear of being wrong, how do you break through analysis paralysis and how do you make sure you’re getting the most out of the top leaders? Scott Bennett, founder of Invest with Rules and IWR Advisors, joins the “Investing with IBD” podcast to explain all this and more.

New traders, new thinking. Author Jack Schwager profiles the next generation of market wizards, including a musician who made nearly $500 million in cumulative profits and a Hong Kong-born trader who attained a 108%+ compound annual growth rate on agriculture futures and more. The trick? Schwager explains in this week’s “Investing with IBD” podcast.

Family matters here. Mish Schneider, chief strategist at MarketGauge.com, discusses market momentum and its effects on commodities, regional banks and more. She also gives an update on the modern “economic family,” a benchmark that helps investors assess market direction. Tune in to learn about the semiconductor industry’s continued strength, AI’s longevity and why small caps still matter.

Preparation, meet opportunity. Jim Roppel of the Roppel Report returns to the “Investing with IBD” podcast to discuss not just his bullish thesis on AI, but the pitfalls that await investors and the hard work needed to translate favorable trends into a profitable outcome.

Stay in the game. Conviction can help traders manage concentrated positions, but requires one key characteristic to survive high-stakes plays. Charles Harris, portfolio manager at O’Neil Global Advisors discusses how to protect yourself, manage drawdowns and live to fight for another trading day.

Taking profits is an art and a science as traders attempt to maximize their gains without suffering big drawdowns. Revere Asset Management's Ted Zhang and Connor Bates discuss how they built their top-notch trading routines and how they go about selling into strength.

How can you tell a stock is running out of steam or just gaining momentum? IBD chief content officer Chris Gessel explains how he uses this common yet game-changing technical indicator to spot buying and selling points in his trading routine.

How can you tell if a price swing is a distraction or a signal? Looking at the big picture helps. Leoš Mikulka, trader and 2024 U.S. Investing Championship top performer, explains how he analyzes charts using multiple time frames to confirm stock trends and pinpoint high-probability entries for consistent results.

When it comes to a V-shape rally, hesitation can be costly. But how can you spot when stocks are quickly changing direction? Leif Soreide, founder of Champion Team Trading and a 2019 U.S. Investing Champion, shares the tactics he uses to identify a market’s comeback before it's obvious and how investors can shift gears early when a rally takes off.

A powerful market rally is underway, meaning it's more important than ever to stay on top of where the money is flowing. Jack Kosar, vice president of investment strategy at Asbury Research, sheds light on the market signals influencing portfolio allocations right now and how to manage risk in the current investing climate. He also shares how Asbury was able to find outperformance in a volatile first quarter.

Better trades, now made even faster. Mike Webster, senior market strategist at IBD, joins the Investing with IBD podcast to discuss the new upgrades to MarketSurge. He explains how new features like upgraded lists, proprietary ratings and changes to pattern recognition can help traders save time and get to the right trades faster than before.

Traders must change and adapt with the market. But that doesn’t mean switching strategies altogether. Dan Fitzpatrick, president of Fitzpatrick Trading Group and founder of Stock Market Mentor, explains why it’s better to become an expert in one single style of trading and adjust it to different markets. He also discusses the most important indicators for traders during a market downtrend.

What can MarketSurge do for you? Arnie Gutierrez, senior premium product coach at IBD and IBD Live panelist, joins the Investing with IBD podcast to walk through the new MarketSurge platform. Together with special host Alissa Coram, executive editor of multimedia at IBD, learn how the platform helps investors make smarter and stronger trades and follow some real-world examples of how to use its new premium features.

Learn the signature fade with the uncrowded trade. Jason Shapiro, founder of the Crowded Market Report, joins the Investing with IBD podcast to discuss why trades are suddenly getting uncrowded, sudden interest in 30 year bonds, and the one thing that stops Shapiro from doing any kind of trade.

It’s great to be able to predict what will happen next in volatile markets. But what if you didn’t need to know in the first place? Jay Woods, chief market strategist at Freedom Capital Markets and a professor of technical analysis at Fordham University, explains how to handle volatility and navigate changing headlines. He also takes a look at stocks like IGV, ORCL and the Magnificent 7.

Tracking leadership rotation from growth to value and from value to defensive doesn’t need to be expensive. David Keller, president and chief strategist at Sierra Alpha Research, explains where he sees underappreciated value set to improve over time and trades.

Finding IPOs, following them … and knowing when to strike. Greg Morton takes a deeper dive into the mechanics behind finding investable stocks after their market debuts and how to put candidates through their paces. Morton also takes a look at recent IPOs like Medline (MDLN) and how to consider things like underwriters, liquidity and management.

If you’re flustered about Fibonacci retracements, crazy about candlesticks or just think charts are better with a Bollinger band, the new MarketSurge platform has you covered. Scott St. Clair, Premium Product Group Senior Manager at IBD, reviews the new MarketSurge beta and explains how you can put it to use right away.

Tech is transforming today’s market. Nancy Tengler, CEO and CIO of Laffer Tengler Investments, discusses how to make sure you don’t miss out on the best, and what to look for in stocks.

Matt Caruso, president of Caruso Insights, explains why the current market’s consolidation echoes markets of the 90’s and the internet boom. He joins the “Investing with IBD” podcast to explain why he sees today’s market as more of a midway point, not the end.

Everyone knows what the hot stocks are and when to buy them. But knowing when to cut losses, exercise patience and concentrate on leaders is just as important. George Tkaczuk, portfolio manager at RCM Wealth Advisors, tells the “Investing with IBD” podcast how best to manage your trading psychology and explains why a consistent process is so critical.

Rather than asking how bullish or bearish the market is, here’s why it might be better to consider your own timeframe instead. Katie Stockton, founder and managing partner of Fairlead Strategies, discusses trade tactics that can keep your portfolio flexible in both the short-term and long-term.

Investing might be better by looking beyond our borders. Foreign stocks are outperforming domestic markets in key areas like banking, but aren’t getting much notice from U.S. investors. David Cox, senior portfolio manager at Raymond James, explains why investors get fixated on domestic investing and how to find outperformance elsewhere in the world, including in crypto, metals and more.

The sectors that worked in 2025 … and the sectors that could surge in 2026. Thomas Carr, founder and CEO of DrStoxx.com, discusses what to look for in the next explosive sector and how to find it.

Ever notice how some companies can still break into a strong run, even after deep declines? Hold your breath and take the plunge. IBD’s David Saito-Chung explains why deep bases shouldn’t be ignored, how to identify them and what to do when you see one.

Sure, 2025 saw stocks, degens, trends and trades. But what about rates, get rich quick themes, “cowboy accounts” and moderate millionaires in 2026? Gunjan Banerji, reporter at the Wall Street Journal, brings her expertise as the lead writer for live markets coverage to remember the trades and trends that defined the past year … and what to expect in the next.

Coloring books, buypoint calculators, discipline and routines? It’s not the latest back-to-school craze, but how investor Greg Morton adjusts and applies the IBD Methodology. He joins the “Investing with IBD” podcast to discuss how he reduces complex trading strategies into simple, easy-to-follow daily schedules.

It’s not a crystal ball … but we think it comes pretty darn close. Jeffrey Hirsch, editor of the Stock Trader’s Almanac, joins the “Investing with IBD” podcast to discuss the Fed’s next moves, why the election cycle matters to traders, and the January trifecta. He also talks about seasonal patterns and how to prepare your portfolio whether you’re focused on short-term trades or long-term gains.

Seeing green in share repurchasing programs? Simon Erickson, founder and CEO of 7 Investing, joins the “Investing with IBD” podcast to discuss why he sees winners in overlooked, undervalued stocks with solid buyback plans. He also talks about the challenges around consumer spending and the opportunities it creates for overlooked stocks like Cava (CAVA) and Lululemon (LULU).

Inaction is also a valid trading action. Jason Shapiro, founder of the Crowded Market Report, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss his contrarian market trades. He also explains how he gauges market liquidity and one key reason why he’s sitting on the sidelines of today’s market.

It’s more than just a feeling, it’s a quantifiable change in market models. John Kosar, market strategist and portfolio manager at Asbury Research joins Investor’s Business Daily’s “Investing with IBD” podcast to explain the shift he’s seeing in market factors. He also discusses the best tactical and strategic responses from investors to get ahead of the mood shift as 2026 approaches.

The bull market that started with generative AI is showing no signs of slowing down. Joe Fahmy, portfolio manager at Zor Capital, joins Investor’s Business Daily’s “Investing with IBD” podcast this week. He explains why he thinks the good times are set to continue — and the indicators that mark the difference between a shakeout and the end of a rally.

OK, so we’ve got the Fed’s rate cuts and positive earnings, right? Then why are we seeing stronger opens, weaker closes and fewer stocks trading above their moving averages? Joe Mazzola, head trading and derivatives strategist at Charles Schwab, explains on IBD’s “Investing with IBD” podcast.

Markets are moving higher … but fewer stocks are participating in those rallies. Mark Minervini, two-time U.S. investing champion and founder of Minervini Private Access explains the signs he sees in the market’s most recent breakout.

Don’t worry about the future — trade in the present. Tom Basso, enjoytheride.world founder and author of The All-Weather Trader, explains why predicting is pointless and how to stay ahead in today’s markets. He also talks about what’s making investors nervous and how to keep yourself grounded.

The best strategy is the one you can actually execute. Vibha Jha, longtime top performer in the U.S. Investing Championship, discusses the importance of figuring out what works for investors and how to keep doing it consistently.

Can Tom Sosnoff, founder of Tastytrade and Thinkorswim, do it again (but better)? The serial entrepreneur discusses options, wealth management and why he still sees a gap for one more financial platform.

Use historical data to your advantage. Chris Gessel, chief content officer at Investor’s Business Daily, joins the “Investing with IBD” podcast to discuss regression channel lines and how to use them. He also shows how he used them for leading stocks like Robinhood (HOOD) and Credo Technology (CRDO).

Are your market indicators primary, secondary … or tactical? Recognize when the market is changing with these new twists on time-tested indicators. Jack Kosar, vice president of investment strategy at Asbury Research, discusses the tools he uses to track market changes.

Preparing a financial withdrawal plan is a process without a one-size-fits-all solution. Bill Bengen, author of “A Richer Retirement” and creator of the 4% rule, discusses the rules you should consider when starting a retirement plan. He also talks about how to adapt to changes in the market and ways to make your retirement last.

What happens when things get extended … and what should you expect when pullbacks occur? Eric Krull, founder of Krull Asset Management and co-author of “The Lifecycle Trade,” explains how to stay in sync with the market. He also discusses recent IPOs and the importance of patience when considering a buy.

It’s a choose-your-own-adventure, but for your portfolio. Mark Ritchie II joins Investor’s Business Daily’s “Investing with IBD” podcast and discusses what to do when your trades don’t always go your way. He discusses how you can find your own trade style, figure out the stock numbers that matter, and why it’s never too late to turn around your performance.

Looking forward to new IPO debuts? Kathy Donnelly, investing coach and co-author of “The Lifecycle Trade,” joins Investor’s Business Daily’s “Investing with IBD” podcast to take a look at how to handle promising IPO stocks.

Where are some of the market’s most nimble investors headed? How does a major trading platform grow with the app-centric retail investor as they enter the wealth-building stage? Steve Quirk, chief brokerage officer of Robinhood Markets, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss the present and future of investing.

What if you could trade without letting your emotions, like fear and greed, get in the way? Could you rely on your trading rules to tell you what’s ahead in the markets instead of forecasting? John Bollinger, president of Bollinger Capital Management, explains the advantages of having a mechanical trading system.

Don’t think of investing as peering into a crystal ball, think of it more like checking the wind direction and monitoring your gauges. David Keller of Sierra Alpha Research discusses how to approach market shakeups and shifting conditions with a steady hand. He also talks about how he handled last week’s market turbulence.

Want to play earnings season without taking on massive risk? While buying stocks ahead of quarterly reports can be tricky, options strategies can let investors minimize their downside while still participating in potentially big moves. Bob Lang, founder and chief options strategist at ExplosiveOptions.net, shares his approach to options trading during earnings season.

Outrageous growth and not enough investor money? Jason Shapiro, founder of the Crowded Market Report, joins the Investing with IBD podcast to discuss why this sector is set to surge on the generative AI trade — but is often overlooked by investors.

Surf’s up, investors. Don Vandenbord, chief investment officer at Revere Asset Management, discusses how he built a new portfolio from scratch after a new wave of follow-through days in the current market rally.

Are we seeing the “stag-” or maybe just the “-flation?” Mish Schneider, chief market strategist at MarketGauge, joins the Investing with IBD podcast to talk about how to trade defensively even in a resilient market. She also gives us a read on the economy and discusses the possibilities and pitfalls facing traders.

Circle, CoreWeave, eToro, Chime. No, it’s not a grade school chant, but a small sampling of the companies that have gone public just this year. Ken Shreve, senior markets writer at IBD, joins the “Investing with IBD” podcast to share tips on how to trade high-octane IPO stocks while managing risk appropriately. He also explains what’s behind the new IPO boom and how it compares to the previous SPAC mania and other public debuts in recent years.

What should traders make of a market that’s seeing more bullish expectation breakers than ever? Jim Roppel, founder of Roppel Capital Management and author of The Roppel Report, joins Investor's Business Daily's “Investing with IBD” podcast to explain why the market remains so upbeat and how traders should handle their portfolios accordingly.

When a potential secular bull market seems here to stay, but headline risks abound, let experience be your guide. Ralph Acampora, CMT and co-founder of the CMT Association and Jay Woods, chief global strategist at Freedom Capital Markets, join a special double feature of Investor's Business Daily's “Investing with IBD” podcast.

Watch and learn. Scott Bennett, founder of InvestWithRules.com talks about how to understand moves from institutional investors and make profitable trades by following the big money. He also gives his take on the positives he sees in this market’s technical indicators and discusses his method for quickly filtering through U.S. traded stocks to create his model portfolio.

Do you like trading high-octane stocks? IBD’s Mike Webster shares whether or not it’s worth investing when the risk is high, and how to help determine a stock’s risk through assessing its average true range.

A combination of follow-through days and a key bullish signal are making Joe Fahmy, managing director at Zor Capital, optimistic about the market. He shares what he’s looking for and why he thinks he sees market momentum, plus a firsthand reaction to Nvidia’s quarterly results, in Investor’s Business Daily’s “Investing with IBD” podcast.

Trading the current AI stock boom like it’s 1998? Charles Harris, portfolio manager at O’Neil Global Advisors, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss the important lessons Tesla stock taught him and the parallels he sees with Apple’s phenomenal long-term move.

Be cautious at first, even in a market that’s finally showing some bullish signals. Arnie Gutierrez, senior premium product coach at IBD, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss how to narrow down your watchlist after the market follows through and what exactly pyramiding into a position means.

It’s time to transition away from cash and dip your toes back in the water — but with the market still potentially in for a bumpy ride, Mark Minervini of Minervini Private Access discusses the tactical decisions he’s making with his portfolio. Learn why patience is a virtue and how to read the signs that indicate when to get more aggressively involved at the right time.

Spacing out a bit in a tumultuous market? Here’s why Andrew Chanin, CEO of ProcureAM is looking for otherworldly innovation in stocks like Rocket Lab and ASTS, even in a risk-on investing environment. But it’s not all about being starry-eyed: Chanin explains why other space-related names could see a rougher time ahead.

If you don’t quite know how to think about the ramifications of tariffs, we have a podcast just for you. IBD deputy editor Ed Carson discusses the contradictions of a global trade war with the U.S. at the center and takes a look at the losers and winners (yes, really). He also looks at how to handle the news-driven rollercoaster market conditions.

All it takes is a fraction of time to gain a lifetime of trading serenity. Tom Basso, enjoytheride.world founder and author of The All-Weather Trader, joins the “Investing with IBD” podcast to discuss how to adjust position sizes, spreads and stops for volatility.

There’s selling in the market, but where is the money going? John Kosar, chief market strategist and portfolio manager at Asbury Research and Jack Kosar, vice president of investment strategy at Asbury Research, join the Investing with IBD podcast to discuss the quantitative side of market research, sentiment and volatility.

It’s a new market environment compared with the past, but that doesn’t mean there aren’t chances to make money. Brian Shannon, founder of Alphatrends.net, discusses techniques like adjusting position sizing and trade time frames, all to help you keep making money — even when markets disagree.

Uncertain markets can create blink-and-you’ll-miss-it opportunities. Sometimes traders tend to tune out and miss the signals of a change in trend. Scott St. Clair, senior premium product group manager at IBD, discusses the tools and methods you need to stay prepared and how traders can know when to get out — and how to get back in.

Joe Mazzola, head trading and derivatives strategist at Charles Schwab, discusses everything from sentiment and optimizing your capital allocation to the market attitude indicators investors use — and even what to do when the indicators don’t align.

Study up and stay safe. David Saito-Chung, IBD Deputy Markets Editor, discusses the difference between market rotations and corrections, the problem with relative winners in a market correction and shares his insights on investor psychology. He also discusses growth versus value stocks and focuses on medical and healthcare stocks.

When breadth is poor and fewer sectors are working, trading is in fact … easier? Dan Fitzpatrick, founder of Stock Market Mentor, discusses why the market is still trying to figure out where to go next — and how you can get ahead of the crowd by taking a step back.

The best traders improve their performance with lessons from both long-term and short-term trading styles. Vibha Jha, trader and a top performer in the the United States Investing Championship, takes on Duolingo (DUOL), Nvidia (NVDA) and more. She also talks about her trading rules, her positions and why it’s okay to leave a little bit of money on the table.

Setting up a credit spread in a choppy market like this is one thing. Deciding what to do about it afterwards is another matter entirely. Harold Morris, MarketSurge senior product coach, joins Investor’s Business Daily’s “Investing with IBD” podcast to talk about credit spreads and how they can help you deal with the choppiness we’re seeing in today’s market.

Adding leveraged ETFs into your portfolio is a bit like having a breakfast cereal: only best as part of a balanced mix. But if NVDL, TSLR, PTIR and CONL have you doing double-takes, be sure to remember the pitfalls and dangers of investing in them. Will Rhind, founder and CEO of GraniteShares, discusses the warnings around leverage and what to do when aggressive trades go sideways.

It’s that time of the four-year cycle again. Post-election news ushers in another seasonal pattern in markets. Jeff Hirsch, editor of the Stock Trader’s Almanac, breaks it down on the Investing with IBD podcast, and explains why DeepSeek is not the end of the U.S. AI world.

Did your portfolio take a hit as AI stocks got slammed? Insure your trades against black swan events and predictable upheavals by mastering hedges. Matt Caruso, president at Caruso Insights, talks hedging and why he still sees innovation yet to come from generative AI.

Sometimes, you get a great investing idea. But how can you tell if it’s actionable? Nancy Tengler, CEO & CIO of Laffer Tengler Investments, discusses the nine quantitative — and three qualitative — metrics she uses to create opportunities for long-term investment plays. She discusses her entry into Tesla’s recent run, the one thing she looks for in earnings, and why technicals still matter.

Long-term investments pay off for traders with patience, but they can be difficult to find with short-term trendlines and indicators. Look to the future with David Cox, senior portfolio manager at Raymond James Ltd. He discusses how pairing stock fundamentals and technicals can help investors find stocks that massively outperform the market over years.

No one wants to be a one-hit wonder. Briefly outperforming the market isn’t enough — what matters is learning how to continue moving the needle in your portfolio with a strategy that’s sustainable. Alissa Coram, executive editor of multimedia at Investor’s Business Daily, joins the “Investing with IBD” podcast to discuss how she doubled her portfolio within a year, her buy rules, sell signals and how to fit active trading into a busy lifestyle.

Let the market guide you. Irusha Peiris, portfolio manager at O’Neil Global Advisors, strikes the balance between rolling with the punches and getting ahead of the market when opportunities present themselves. He also looks back at 300 episodes of the “Investing with IBD” podcast and the key moments and lessons that defined him as a trader.

Not every sell signal is the same. Kathy Donnelly, investing coach and co-author of “The Lifecycle Trade,” joins Investor’s Business Daily’s “Investing with IBD” podcast to explain why good trading isn’t necessarily about selling at any one signal, but finding the limitations and exceptions with your holding rules. She also discusses applying trade rules to stocks like Cava (CAVA), Netflix (NFLX) and AppLovin (APP).

Stay in control, no matter where your trading game takes you. Leoš Mikulka, trader and leading participant in the 2024 U.S. Investing Championship with a gain of more than 900% in 11 months, shares how he identifies the themes and setups that led to his investing success. Plus, he discusses the competitive edge he brought from football to investing and how he fits trading into his weekly routine. Mikulka also discusses the action in stocks like GE Vernova (GEV), NextNav (NN) and IonQ (IONQ).